ACIP Altered Immunocompetence Guidelines for Immunizations

Angie Szumlinski News

This section incorporates general content from the Infectious Diseases Society of America policy statement, 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (1), to which CDC provided input in November 2011. The evidence supporting this guidance is based on expert opinion and arrived at by consensus. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html

Influenza vaccine, syringe, and vials.

Influenza Vaccine – Risk of COVID-19

Angie Szumlinski Studies

Early evidence suggests that COVID-19 patients with positive influenza A immunoglobulin M (IgM) had a lower risk of mortality and severe COVID-19 illness compared with those who showed a negative IgM status. It has also been reported that influenza vaccination is negatively associated with COVID-19 mortality in older adults; in Brazil, a patient registry showed that patients who recently received …

Inactivated SARS-CoV-2 Vaccines

Angie Szumlinski Studies

Effective vaccines against COVID-19 are urgently needed to control the global pandemic. More than 280 candidate vaccines are in development worldwide, 23 of which are already in phase 3 trials using different platforms. In this phase 3 randomized trial in adults, 2 whole-virus inactivated vaccines showed efficacy of 72.8% and 78.1% against symptomatic COVID-19 cases. The 2 vaccines had rare …

The Fat Lady Sings

Angie Szumlinski Studies

In an article published in Forbes magazine, three companies are currently leading the way to develop a vaccine that will be effective against all variants of COVID-19. The goal of this research is to possibly prevent a future pandemic from variants of the COVID-19 virus. The current providers of COVID-19 vaccines (Pfizer, Moderna and J&J) are focusing their attention on …

COVID-19 Vaccine – Nasal?

Angie Szumlinski News

There is a ton of research going on today regarding not only the current process for vaccines to be administered via muscular injection, but new ideas too and to date, the information is promising! Think about having a COVID-19 vaccine in a nasal application versus injected. That is what the scientists are studying today. The science behind it is pretty …

Another Opinion on Boosters

Angie Szumlinski Health

According to David Kessler, M.D., chief science officer of COVID response for the Department of Health and Human Services, the federal government is planning to have booster doses of the COVID-19 vaccine available for American people if needed. “The increased age, waning antibodies over time and new variants increase the probability that booster doses may be needed,” Kessler told Congress. …

Anxiety-Related Adverse Events – Janssen Vaccine

Angie Szumlinski News

“On April 7, 2021, after 5 weeks’ use of the Janssen COVID-19 vaccine under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA), CDC received reports of clusters of anxiety-related events after administration of Janssen COVID-19 vaccine from five mass vaccination sites, all in different states. CDC interviewed staff members from the five mass COVID-19 vaccination sites that reported …